Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2963 results

Clinical Trials / Jun 03, 2026

Secukinumab Open Label Roll-over Extension Protocol
Clinical Trials / Jun 26, 2026

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trials / Jun 05, 2026

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
Awards and recognition
Clinical Trials / Jan 31, 2025

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Clinical Trials / May 16, 2024

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Supporting you in producing high-quality medicines for patients worldwide – Novartis Contract Manufacturing factsheets
Executive Committee
Biography / Aug 19, 2021

Vasant Narasimhan
Press release / Jul 06, 2026

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

Adds potential first-in-class, N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis…

‹ Previous page
1
…
16
17
18
19
20
21
22
…
297
› Next page